Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.

JSON

Blixt L, Gao Y, Wullimann D, Murén Ingelman-Sundberg H, Muschiol S, Healy K, Bogdanovic G, Pin E, Nilsson P, Kjellander C, Grifoni A, Sette A, Sällberg Chen M, Ljunggren HG, Buggert M, Hansson L, Österborg A

Blood 140 (22) 2403-2407 [2022-12-01; online 2022-09-24]

Category: Biochemistry

Category: Health

Funder: KAW/SciLifeLab National COVID program

Funder: VR

Type: Journal article

PubMed 36150168

DOI 10.1182/blood.2022016815

Crossref 10.1182/blood.2022016815

pmc: PMC9512527
pii: S0006-4971(22)01417-3